March 2025 - Cancer Currents Blog
-
Intensive Program Helps People Being Screened for Lung Cancer Quit SmokingResults from a large NCI-funded clinical trial show that a comprehensive program that integrates intensive counseling and cessation medications may be a particularly effective way to help smokers being screened for lung cancer quit.
-
New on NCI’s Websites for March 2025NCI periodically provides updates on new websites and other online content of interest to the cancer community. See selected content that has been added as of March 2025.
-
Combination Therapy for Metastatic Prostate Cancer Helps Some Men Live LongerFor men with metastatic castration-resistant prostate cancer, initial treatment with enzalutamide (Xtandi) combined with talazoparib (Talzenna) may help them live longer than getting enzalutamide alone, according to updated results from a large clinical trial.
-
TACE-Based Treatment Combinations Effective Against Intermediate-Stage Liver CancerResults from two clinical trials show that combining a procedure called TACE with an immunotherapy drug and angiogenesis inhibitor improves how long people with intermediate-stage liver cancer live without their disease returning or getting worse.
-
Scientists Find Genetic Changes Linked to Cancer in ChildrenCertain inherited genetic changes are likely involved in the development of some cancers in children, a new study shows. The changes, called structural variants, were linked with a small percentage of children with neuroblastoma, Ewing sarcoma, and osteosarcoma.